{{Rsnum
|rsid=445114
|Chromosome=8
|position=127310936
|Orientation=plus
|GMAF=0.4596
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=LOC101930033
|Gene_s=LOC101930033
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 14.2 | 47.8 | 38.1
| HCB | 20.4 | 59.1 | 20.4
| JPT | 21.2 | 49.6 | 29.2
| YRI | 51.0 | 40.8 | 8.2
| ASW | 45.6 | 45.6 | 8.8
| CHB | 20.4 | 59.1 | 20.4
| CHD | 18.3 | 48.6 | 33.0
| GIH | 28.7 | 54.5 | 16.8
| LWK | 48.2 | 42.7 | 9.1
| MEX | 15.5 | 43.1 | 41.4
| MKK | 46.5 | 43.9 | 9.7
| TSI | 11.8 | 48.0 | 40.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=19767754
|Title=Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility
|OA=1
}}

{{omim
|id=611100
|rsnum=445114
}}

{{PMID Auto GWAS
|PMID=21743057
|Trait=None
|Title=Genome-wide association study identifies new prostate cancer susceptibility loci.
|RiskAllele=T
|Pval=5E-7
|OR=1.2200
|ORtxt=[1.12-1.32]
|OA=1
}}

{{PMID Auto
|PMID=20690139
|Title=Meta-analysis of genome-wide and replication association studies on prostate cancer.
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs445114
|overall_frequency_n=56
|overall_frequency_d=126
|overall_frequency=0.444444
|n_genomes=41
|n_genomes_annotated=0
|n_haplomes=50
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=23159463
|Title=Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}